These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31229293)

  • 1. Successful lung transplantation from a hepatitis C RNA-positive donor to a hepatitis C treatment-experienced recipient with cystic fibrosis.
    Harano T; Haidar G; Schaheen L; Morrell MR; Pilewski JM; D'Cunha J
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):e155-e157. PubMed ID: 31229293
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
    Campos-Varela I; Agudelo EZ; Sarkar M; Roberts JP; Terrault NA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful repair of donation after circulatory death lungs with large pulmonary embolus using the lung organ care system for ex vivo thrombolysis and subsequent clinical transplantation.
    Luc JG; Bozso SJ; Freed DH; Nagendran J
    Transplantation; 2015 Jan; 99(1):e1-2. PubMed ID: 25525922
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C.
    Yu ML
    Hepatology; 2011 Apr; 53(4):1403; author reply 1403. PubMed ID: 21480349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Predictive value of virological response on sustained virological response in hepatitis C patients].
    Zhou YQ; Wang XH; Fan Y; Zhu Y; Tan WT; Mao Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):944-6. PubMed ID: 20038340
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents.
    Berzsenyi MD; Roberts SK
    J Gastroenterol Hepatol; 2010 Apr; 25(4):655-6. PubMed ID: 20492322
    [No Abstract]   [Full Text] [Related]  

  • 8. Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.
    Campos-Varela I; Esteban JI; Bes M; Caralt M; Allende H; Rodríguez-Frías F; Salcedo MT; Sauleda S; Charco R; Guardia J; Esteban R; Castells L
    J Viral Hepat; 2014 Oct; 21(10):e118-28. PubMed ID: 24620835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries.
    Ceylan B; Arslan F; Yardimci C; Fincanci M; Özgüneş N
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):493-4. PubMed ID: 24598385
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin resistance and sustained virological response in hepatitis C: from bench to bedside.
    Romero-Gómez M
    Liver Int; 2011 Jan; 31(1):1-3. PubMed ID: 21062414
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin.
    Biermer M; Berg T
    Gastroenterology; 2009 Jul; 137(1):390-1. PubMed ID: 19486953
    [No Abstract]   [Full Text] [Related]  

  • 12. Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.
    Bernabucci V; Ciancio A; Petta S; Karampatou A; Turco L; Strona S; Critelli R; Todesca P; Cerami C; Sagnelli C; Rizzetto M; Cammà C; Villa E
    World J Gastroenterol; 2014 Nov; 20(44):16726-33. PubMed ID: 25469044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we use the "C" word with confidence? Cure for chronic hepatitis C.
    Chen JY; Chung RT
    Gastroenterology; 2011 Mar; 140(3):766-8. PubMed ID: 21256845
    [No Abstract]   [Full Text] [Related]  

  • 14. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
    Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
    Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.
    Taneja S; Duseja A; De A; Kumar V; Ramachandran R; Sharma A; Dhiman RK; Gupta KL; Chawla Y
    Nephrology (Carlton); 2018 Sep; 23(9):876-882. PubMed ID: 28703905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
    Antonelli G; Riva E; Maggi F; Vatteroni ML; Simeoni E
    J Infect Dis; 1999 Oct; 180(4):1411-2. PubMed ID: 10479188
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice.
    Te H; Doucette K
    Clin Transplant; 2019 Sep; 33(9):e13514. PubMed ID: 30817047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of interferon and ribavirin combination therapy in sixty-two patients with chronic hepatitis C originating from a single blood donor].
    Liu SD; Cheng ML; Ren H; Yang QK; Shu DY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):589-92. PubMed ID: 23207152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.